Novo Nordisk Will Cut Some U.S. Insulin Prices by Up to 75% Starting Next Year

March 15, 2023

(NPR) – Novo Nordisk will start slashing some U.S. insulin prices up to 75% next year, following a path set earlier this month by rival Eli Lilly. The Danish drugmaker said Tuesday that pre-filled pens and vials of long- and short-acting insulins will see list price reductions. They include Levemir, Novolin, NovoLog and NovoLog Mix70/30. Novo also will drop the list price of unbranded products like Insulin Aspart to match the lower price of the branded insulins. (Read More)